Abstract 15685: Selective Improvement of Pulmonary Arterial Hypertension With Dual ETA/ETB Receptors Antagonist in the Apolipoprotein E-/- Model of PAH and Atherosclerosis

Circulation(2016)

引用 0|浏览2
暂无评分
摘要
Introduction: Pulmonary arterial hypertension (PAH) is a devastating condition and without treatment is associated with a life expectancy of 2.8 years. Apolipoprotein E deficient (ApoE-/-) mice dev...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要